Cedars Sinai
J

IO in Advanced HCC: Does Nivo Show Superiority vs. Pembro? What Is the Advantage of Atezo + Bev vs. Sorafenib? Should Nivo+Ipi Be Our 2L Therapy Choice?

By Cedars Sinai FEATURING Jorge Marrero, Willis C. Maddrey
By Cedars Sinai FEATURING Jorge Marrero, Willis C. Maddrey
82 views
March 10, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Recommended

Houston Methodist

Inaugural Houston Methodist Neal Cancer Center GI Oncology Symposium

Fri, Dec 6, 2024
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
22:55

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views
18:21

New

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

376 views
20:09

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

371 views
10:57

Y90 Radioembolization for Locally Advanced HCC

UCLA Health

S. Padia

632 views
13:05

ESMO 2024 Summary: Highlights in HCC

2024 ESMO Annual Meeting Insights Hub

R. Kim, T. Biachi

196 views
15:30

Updates in Combination Therapy for HCC

Yale Cancer Center

S. Stein

456 views
04:39

ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - P…

2024 ESMO Annual Meeting Insights Hub

J. Llovet

197 views
25:09

ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

375 views
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

237 views
26:59

2023 AASLD Guidance for HCC

University of Texas Southwestern Medical Center

A. Singal

816 views
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views
09:56

ESMO 2024 Insights: HIMALAYA - 5-Year OS of Tremelimumab + Durvaluma…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

168 views
27:48

Current Approach to Frontline Systemic Therapy for Advanced Hepatoce…

Lionel Kankeu Fonkoua

260 views
13:58

ASCO® GI 2024 Summary: "HCC Key Studies Including EMERALD-1 & IMbrav…

Insights from 2024 ASCO® GI Annual Meeting

R. Kim, T. Biachi

434 views
15:53

Understanding HCC: Perspectives on Diagnosis, Risk Factors, and Trea…

Yale Cancer Center

A. Jaffe

326 views
05:40

New

ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs.…

2024 ESMO Annual Meeting Insights Hub

H. Karachiwala

131 views
14:28

ESMO 2024 Summary: Updates in HCC and Impacts on Practice

2024 ESMO Annual Meeting Insights Hub

H. Babiker

151 views
21:11

Hepatocellular Carcinoma: Current Management Strategies

Stanford Medicine

R. Dhanasekaran

230 views
09:41

ASCO® 2024 Summary: "HCC Highlights From the CheckMate 9DW and CARES…

2024 ASCO® Annual Meeting Insights Hub

A. Vogel

213 views
AUTOPLAY